AtsSTRACT Purpose: We evaluated the adaptability and the effrcacy of a cyanoacrylic glue for the conservative treatment of urinary fistulas of diff'erent etiologies using an endoscopic, percutaneous or endovaginai approach. lVlaterials and Methods: From May 1998 to July 2004, 13 patients with long lasting iatrogenic andlor inflammatory urinary fistulas were treated conservativeiy with endoscopic, percutaneous or endovaginal application of 1 to 3 cc ofcyanoacrylic glue.
Klv Wonns: adhesives, cyanoacrylates, urinary fistula Since 1996 our ì)epartment has been using a synthetic persistent iatrogenic and/or inflammatory urinary fistulas cyanoacry'ic sealant in major pelvic surgical procedures or were admitted to our department. Once previous attempts of nephron sparing surgery to prevent intraoperative and posturinary drainage had failed, the patients were treated conoperative bleeding and/or lyrnphoryhea. This glue (Glubran servatively with endoscopic, percutaneous or endovaginal 2@) is composed by n-butyl 2-cyanoacrylate (monomer) and cyanoacrylic glue application. rnetacryloxysulpholane (monomer). It has high adhesive and
The cases in our series had different etiologies, including 1 hemostatic properties. Once its polymerization is completed, prostato-perineal fistula following incorrect urethral catheit }ecomes a thin elastic impermeable filne which is resistant terization in the perioperative period of a Miles abdominoto stretching. The hemostatic and adhesive properties of cy-perineal amputation for rectal adenocarcinoma. This patient anoacrylateiepend mainly on a signifrcant decrease of actihad undergone transurethral prostate resection for benign vated partial thromboplastin tirne. In adtlition, cyanoacryprostate hyperplasia. We also treated 2 neovesicoileal fistulate properties include goocl biocompatibility, gradual las ( fig. 1 ), 2 anastomotic neovesicourethral fistulas, 1 reabsórption without foreign body response and a shr:rt po-neovesicocutaneous frstula ( fig.2 ) complicating radical cyslyrnerization tirne (less than 90 seconcls) even in a wet envitectomy rvith a Camey II orthotopic bladder substitution for ionment.l Inllammatory fistulas and iatrogenic persistent invasive transitional blaclder cancer, 2 vesicosigmoid inflamurinary Iistulas complicating pelvic surgery are usuall;v lÌrst matory fistulas complicating a sigmoid divertic-ulitis, 3 vesitreated with urinary drainage. Once previous conserwative covaginal fistulas (2 compiicating laparoscopic hysterectomy marìeuvels have failed fistulas usually require diffrcult surand l-a subcervical urethral diverticulectomy), 1 vesicouterine fistula complicating a cesarean, and 1 caliceal fistula gical repair.2-'
Various biological agents (thrombin, fibrin, collagen glues) have been tailored for endoscopic anÙor percutaneous use. Technical simplicity and good results of conservative treatments using bioiogical sealants (particularly fibr{n glue), have been reported,s-14 and our previous positive experience with this glue led us to try its aclaptability to treat these cases. Thus, since 1998 we have used this synthetic glue as a rninirrally invasive alternai,ive to traclitional surgery for the treatment of prolonged urinary fistulas of iatrogenic and inflaurmatory etiology._In 2001 we publishecl our preliminary favorable experience.'" acrylic glue. trVith the endoscopic approach the synthetic glue is injected in the fistuious hole and an open-end 6Fr ureteral catheter is inserted through the cystoscope operative channel to attain complete obliteration. As the prostato-perineal fistula was under the bladder it was not necessary to fili the blaclder with saline in this case. In the remaining 6 patients treated endoscopically, the procedure was performecl on patienl,s with a full bladder since the listulous orifices were at bladder level (1 vesicouterine, 2 vesicnsigmoid) or neobladder level (1 neobladcler-ulethrai, 2 neobladcler-i1ea1). In none of the cases rvas it necessary to preventively cannulate the ureters. To facilitate the con:ect placement ofthe giue, taking advantage of its rapid p*lyrnerization time (beginning after:5 to 6 seconds and completed rvithin 60 to 90 seconds), it is useful to use moderately wann saline. The polymerization of cyanoacrylic glue is more f'avorabTe al 45C and it can be performed in a wet environment,.
,A,n open-end 6 Ch ureteral catheter was also used for the 3 percutaneously tleatecl cases. It rvas inserted percutaneously under fluoroscopic guidance using the cutaneous drainage path. In the case of the lower pole caliceal fistula cornplicating a complex pyelonephrolithotomy, the accuracy of the maneuver was monitored with a retrograde pyelogram, which also shorved the absence ofureteral obstruction. In the cases of neovesicourethral leakage Ílom the posterior side of the anastomosis ancl o1' the neovesicocutaneous fistula, respectively rn'ith early and late (20 months) complication of radical cystectomy with orthotopic bladder substitution, the maneuvers \4,ere also perforrnecl under'fluoroscopic guidance and nonitored through a neocystogram.
For the 3 cases ofvesicovaginal fistulas the approach N'as endovaginal. The glue rvas applied with an oxidized regenerated cellulose strip into the fistulous hole, preceded and followed by cystoscopic control. Preparation of the fistula tract, such as scarifrcation, to enhance the formation ofgranulation tissue, was never perfonned. One to 3 ml of cyanoacrylic glue sufficed for all cases. When using a ureteral catheter about 1 ml ofglue is lost inside tlie catheter itseÌf.
At the end ofthe procedule urine t'as drained by a ulethral catheter left for 48 hours for up to 1 lveek. With the lotver pole caliceaÌ fistula the ripper urinary tract rvas drained only by nephrostomy for a *'eek (the Double-J@ ureteral stent previously inserted was removed before the procedure). The nephrostomy was removed a{ter the anteglacle pyelo6pam had excluded the persistence of fistula.
Patienís were followed up clinically and with imaging with excretory urography, computerized tomography (CT) or retrograde cystography at 1 to 3 months after the procedure in Mr:re recently, synthetic cyanoacrylic sealants have been introduced in urology for the nonsurg:ical management of iatrogenic urinary tract frstulas. The main differences between fibrin glue and cyanoacrylic glue are reported in Appendix 2. We have already reported our initial favorable experience with this glue through the endoscopic plugging of 3 persistent iatrogenic lower urinary tract fistulas complicating nrajor pelvic surgery. 15 Other positive experiences using this synthetic glue were Ìecently published in other medical fields.16'17 Mechanical and biological properties ofcyanoacrylic sealants seem suitable for endoscopic or percutaneous r1se, having a crucial role in healing urinary frstulas with this approach.
More recently the usefulness of this sealant was also evaluated at urethral and upper urinary tract levels. Lapointe et al assessed the efficacy of n-butyl cyanoacrylate for the early repair of fistulas after hypospadias surgery in 8 children, attaining fistula closure with good cosnìetic and functional ontcome in 62.5Va.a8 Tekinle and Riera Canals"o et al perforrned upper urinary tract fistula embolization rvith n-butyl 2-cyanoacrylate under fluoroscopic guidance with a percutaneous approach and urinary drainage, and fistula repair was reported in both experiences. In our current series we assessed the value of cyanoacrylic glue for endoscopic, percutaneous and endovaginal use, confirming its adaptability and versatilif along with its safety and efficacy. Ho'wever, regarding safety, some concern was raised about the postoperative risk ofinfertility with vesicouterine frstulas since uterine adherences or tubal occlusion rnay occur as a result of intraluminal cyanoacrylic sealant polymerization. In the singl.e case r:eported in our series, occlusion therapy failed and the fistula was repaired with a conventional surgical approach. However, because of the previously mentioned risk 1ve are not in favor ofusing this procedure for the management of vesicouterine fistulas.
Finally, based on our experience, to optimize the efficacy and predict the probability of cure with this approach' several key points should be noted. 1) The length and width of the fistulous tract are decisive factors. The probability of sealing the fistulous tract is directly related to the length and inversely related to the width. Thus, narrow and long tract fistulas have a higher probability ofbeing sealed because the glue has a narrow passage with the greatest possible surface cnnnection. Thus, we used an oxidized regenetated cellulose strip and a vaginal approach to maintain the glue in the vesicovaginal fistulas" 2) The exact location of the fistulous hole and accurate sealant injection are manclatory. This phase could be much more complex in nephrocutaneous fistulas as the maneuver" must be perforrned under fluoroscopic guidance with a simultaneous retrograde ol antegrade pyelogram.
3) The injection of an unnecessary aillount of cyanoacrylic glue must be avoided. Usually 1 to 3 ml are enough for this purpose. Excess sealant does not irnprove the results and, at the same time, it creates glue clots whose clearance might require ancillary rnaneuvers. 4) The speed ofexecution is important. Cyanoacry'ic glue polymerization tirne is short (less than g0 seconds), thus it is crucial to remove the endoscope along lvith ureteral catheter as soon as the sealant is injected. This w-ill prevent entrapment ofthe ureteral catheter and damage to the encloscope. Therefore, it is useful to keep the endoscope 3 to 4 cm away from the glue injection. 5) Cyanoacrylate sealant appears to be safe. However, its use in vesicouterine fistulas in fertile women is not recommended as there is a high risk of occluding the uterine cavity and uterine tube. 6) Regardless ofthe frstula location' the use of this technique does not seem to affect later conventional surgical repair ofthe fistula (as noticed in our series). tire absence of clinical signs of persisting fistulas. In the absenee of relapse, successive followup was only related to the pathoiogy necessitating the initial treatment (Appendix 1).
RESUL'fS
Median follorvup was 35 months (range 6 to 76). The lasl, control was in February 2005. There was no intraoperative or postoperative mortality. No signifrcant early and late complications were observed. In the first case of vesicosigmoid fistula, 4 months after the sealant application a 2 cm bladder stone hacl developetl on the glue sur{ace protruding in bladder. This complication required endoscopic laser lithotripsy, and the endoscopic sight indicated the area of the previous fistula ivhich rvas completely covered with urothelium. The bladder stone rvas not attached to the previous fistulous hole' In 1 patient rvith a vesicoyaginal fistula and in the case of vesicouterine frstula, endoscopic removal of intravesical redundant polymerized glue with cystoscopic forceps was recluired within 48 hours of glue application. All 3 patients \,vere symptomatic aÍter the procedure (dysuria and hematuria in the frrst after 3 months, strang"ury and urgency in the other 2 after catheter removal).
Occlusion therapy failed in 2 of 13 cases (1 vesicouterine and l-vesicovaginal fistula) in which the fistulas were wider (orifice diameter greater than l-cm) and short. Both patients had persistence of Llrinary incontinence. After 2 months the frrst-patient underwent a subtotal hysterectomy and vesical frstula repair. After 3 months the second patient underwent a fistulectomy rvith epiploon interposition' In the remaining 10 cases fistulas were successfully sealed and no relapses were otrservecl at followup. Operative time vavied depending upon the site ofthe fistulas, the approach and the diffrculties thereafter in locating the fistulous orifrce' In our series operative tirne ranged from 10 to 20 minutes" DISCUSSION Urinary tract fistulas often develop as an ear{y complication of gynecological or urological surgery, or as a result of trauma, inflammatory disease or radititherapy. Urinary drainage by itself is suffieient to cure some small urinary tract Íhtulas, whereas for the complex and larger ones this approach is often ineff'ective. TtrereaÍter, prolonged urinary ìeakage might require diffrcult surgical procedures, potentially burdened by a higher complication rate. Time to surgery can vary depending on the etiology ofthe urinary fistuìis. For instance, in genitourinary flstulas (vesicovaginal and vesicouterine), a waiting period of 3 months is usually reouired. On the other hand, the efficacy of nonsurgical treatments is directly related to precocity. Generally when surgical repair: of the fistula is needed, the waiting period leads to social and psychological distress for patients' Fibrin glue is the injectable biological surgical sealant with the longest followup with regard to the nonsurgical managernent oifistulous disease, as it has been used since the late 1980s for the treatment ofblonchopleural fistulas, perineal, anal and ctllorectal fistulas, as well as urinary tract fistu1as.5-12 A small amount of topically injected fibrin glue is usually used. Morita and Tokue achieved the closure of a neoveJicocutaneous fistula using topical fillrin glue'B Tostain reported on 4 cases ofurinary fist'Lilas (2 ureterovaginal and 2 vesicovaginal.) successlully plugged with librin sealant'11 Sehneider et al reported a 66Vo clos:ure rate in 6 cases treated with endoscopic fibrin sealing ofiatrogenic vesicovaginal fistu1as.12 Welp et ai reported 3 cases of vesicovaginal fistulas sriccessfullyìreated with topical application of fibrin glue.''t Evans et al used fibrin sealant with a direct injection technique in 1-9 patients, 5 of whom were affected by complex .,ri*a.y fistulas. They reported successful fistula repair after
